How technology could cut millions of hospital visits across Europe
Remote care technology is becoming a critical solution to mounting capacity pressures
China: the next Pfizer will be Chinese
We believe that the next Pfizer will be Chinese
China’s spectacular rise reshapes Asia’s pharma future
The balance of power in the global pharmaceutical industry is shifting east
South Korea has been the second most important contributor to the growth of Asian drug innovation
India: from generics giant to innovation powerhouse?
Japan: Asia's Europe?
Makary's successor faces tough task managing FDA amid budget cuts
A prescription for power – China's biotech boom and the new global…
Trump's 100% pharma tariffs will have a limited effect on the sector
Watch: European pharma's fight to stay relevant
European pharma's fight to stay relevant
Transformative or overhyped? The impact of weight-loss drugs on European food…
Europe’s last chance to revive its pharmaceutical innovation power
Europe's pharma industry can be a powerhouse again, but it needs to act fast
Pharma’s Godfather moment: pulled back into tariff uncertainty
The US Supreme Court’s decision to invalidate Trump’s use of emergency authority to impose tariffs is unlikely to derail MFN deals with pharma companies
Dutch healthcare sector set to expand further despite supply constraints
Listen: Pharma 2026 - higher prices, manufacturing migration, China's…
ING Think has analysts all over the world who write about their dedicated region.
Pharma’s 2026 hit list: The White Album
Pharma's 2026 hit list: The White Album
Money (That's What I Want): 2026 is the year of truth for Trump’s…
Hello, Goodbye: Europe loses ground as China becomes powerhouse of innovation
